| Gene symbol | CD1A | Synonyms | CD1, FCB6, HTA1, R4, T6 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1q23.1 | dbXrefs | |
| Description | CD1a molecule | ||||
| GTO ID | GTC3349 |
| Trial ID | NCT05745181 |
| Disease | Acute Lymphoblastic Leukemia | Acute T-Cell Lymphoblastic Lymphoma |
| Altered gene | CD1a |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD1a CAR-T cells |
| Phase | Phase2 |
| Recruitment status | Recruiting |
| Title | Clinical Study of Anti-CD1a CAR-T in the Treatment of R/R Acute T-lymphoblastic Leukemia/Lymphoblastic Lymphoma |
| Year | 2023 |
| Country | China |
| Company sponsor | The Affiliated Hospital of Xuzhou Medical University |
| Other ID(s) | XYFY2022-KL479-01 |
| Cohort 1 | |||||||||
|
|||||||||